SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr.Reddy's Laboratories informs about board meeting proceedings

27 Jul 2021 Evaluate
Dr.Reddy's Laboratories has informed that the Board of Directors of the Company at their meeting held on July 27, 2021 have approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2021. In terms of the above, it enclosed the following: Unaudited Consolidated Financial Results of the Company and its subsidiaries for the quarter ended June 30, 2021 prepared in compliance with International Financial Reporting Standards (IFRS) as issued by International Accounting Standards Board (IASB); Press Release on Financial Results of the Company for the above period; and etc.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Labs. Share Price

1356.85 -19.45 (-1.41%)
30-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1862.70
Dr. Reddys Labs. 1356.85
Cipla 1465.15
Zydus Lifesciences 1112.20
Lupin 2420.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: